Data Insights
No Filter Selected
No Filter Selected
No Filter Selected
No Filter Selected
ABL-105 by ABL Bio for Human Epidermal Growth Factor Receptor 2 Positive Breast Cancer (HER2+ Breast Cancer): Likelihood of Approval
ABL-105 is under clinical development by ABL Bio and currently in Phase II for Human Epidermal Growth Factor Receptor 2...
ABL-105 by ABL Bio for Gastroesophageal (GE) Junction Carcinomas: Likelihood of Approval
ABL-105 is under clinical development by ABL Bio and currently in Phase II for Gastroesophageal (GE) Junction Carcinomas. According to...
ABL-105 by ABL Bio for Bile Duct Cancer (Cholangiocarcinoma): Likelihood of Approval
ABL-105 is under clinical development by ABL Bio and currently in Phase II for Bile Duct Cancer (Cholangiocarcinoma). According to...